Lantheus Holdings
Open
$82.95
Prev. Close
$82.96
High
$82.95
Low
$82.91
Market Snapshot
$5.38B
23.0
4.52
$1.53B
Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The company is headquartered in North Billerica, Massachusetts and currently employs 1,193 full-time employees. The company went IPO on 2015-06-25. The firm's product categories include Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Others. The firm's Radiopharmaceutical Oncology products help healthcare professionals (HCPs) find, fight and follow cancer. The firm's Precision Diagnostic products assist HCPs to find and follow diseases. Its Strategic Partnerships include biomarkers and digital solutions in support of its partners’ therapeutic development, out-licensing agreements for non-core assets and optimization of its assets geographically. The firm's commercial products are used by cardiologists, internal medicine physicians, neurologists, nuclear medicine physicians, oncologists, radiologists, sonographers, technologists, and urologists working in a variety of clinical settings.
emptyResult
Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The company is headquartered in North Billerica, Massachusetts and currently employs 1,193 full-time employees. The company went IPO on 2015-06-25. The firm's product categories include Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Others. The firm's Radiopharmaceutical Oncology products help healthcare professionals (HCPs) find, fight and follow cancer. The firm's Precision Diagnostic products assist HCPs to find and follow diseases. Its Strategic Partnerships include biomarkers and digital solutions in support of its partners’ therapeutic development, out-licensing agreements for non-core assets and optimization of its assets geographically. The firm's commercial products are used by cardiologists, internal medicine physicians, neurologists, nuclear medicine physicians, oncologists, radiologists, sonographers, technologists, and urologists working in a variety of clinical settings.
Recently from Cashu
Lantheus Holdings Focuses on Innovation Amid Strong Earnings Reports from Industry Rivals
Lantheus Holdings Poised for Innovation as Industry Rivals Report Strong Earnings Lantheus Holdings, a leader in diagnostic imaging and radiopharmaceuticals, remains focused on the development and com…
Lantheus Holdings Enhances Diagnostic Imaging with Innovative Solutions and Strategic Partnerships
Lantheus Holdings: Enhancing Diagnostic Imaging through Innovative Solutions Lantheus Holdings, a leader in the field of diagnostic imaging, remains at the forefront of developing advanced radiopharma…
Lantheus Holdings Drives Innovation in Diagnostic Imaging for Cancer Detection and Management
### Lantheus Holdings Focuses on Innovation in Diagnostic Imaging Lantheus Holdings positions itself at the forefront of the medical imaging sector by emphasizing innovation and specialized solutions…
Lantheus Holdings Faces Class Action Over Misleading Projections and Investor Trust Issues
Lantheus Holdings Faces Class Action Lawsuit Over Misleading Projections Lantheus Holdings, Inc. finds itself in the spotlight as The Gross Law Firm announces a notice to shareholders regarding a pote…